SCHEMBL7197121

SCHEMBL7197121

CSc1nc(Cl)c(-c2ccccc2)c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)n1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 3/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CCR9 P51686 4/20 0.43
UQCRB P14927 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
RXFP1 Q9HBX9 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
EDNRA P25101 1/20 0.41
POLB P06746 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MEN1 O00255 1/20 0.40
CRHBP P24387 1/20 0.40
KMT2A Q03164 1/20 0.40
CRHR2 Q13324 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7815226 0.90 EDNRA (0.50) HSD17B2CCR9EDNRA
SCHEMBL8659102 0.81 EDNRA (0.49) HSD17B2KDM4EALDH1A1RXFP1EDNRA
SCHEMBL7198831 0.80 EDNRA (0.49) EDNRA
SCHEMBL7198236 0.78 EDNRA (0.56) EDNRA
SCHEMBL8802241 0.74 EDNRA (0.52) HSD17B2KDM4EALDH1A1EDNRAMEN1
SCHEMBL9493302 0.74 EDNRA (0.51) KDM4EALDH1A1CCR9EDNRA
SCHEMBL7805397 0.73 EDNRA (0.54) EDNRA
SCHEMBL10847225 0.72 HSP90AA1 (0.43) KDM4ECA1CA2RXFP1NPSR1
SCHEMBL8657212 0.71 EDNRA (0.46) KDM4ENPSR1EDNRA
SCHEMBL4844072 0.71 KDM4E (0.49) KDM4EALDH1A1RXFP1NPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596719-B1 Manufacturing those compounds, pharmaceutical compositions containing one or more of those compounds as endothelin antagonists, and a method of treating a subject having a disorder involving endothelin with the compounds of the ACTELIO PHARMACEUTICALS LTD. (CH) 2003-07-22 US disclosed
EP-1137642-A1 BIS-SULFONAMIDES Actelion Pharmaceuticals Ltd. (CH) 2001-10-04 EP disclosed
WO-2001017976-A1 BIS-SULFONAMIDES ACTELION PHARMACEUTICALS LTD (CH) 2001-03-15 WO disclosed
US-5750509-A TREATMENT AGAINST INFECTIONS BY BACTERIA INCLUDING ENTEROCOCCUS, AND STAPHYLOCOCCUS GRUPPO LEPETIT S.P.A. (IT) 1998-05-12 US disclosed
EP-0596929-B1 AMIDE DERIVATIVES OF ANTIBIOTIC A 40926 LEPETIT SPA (IT) 1995-07-26 EP disclosed
EP-0596929-A1 AMIDE DERIVATIVES OF ANTIBIOTIC A 40926. LEPETIT SPA (IT) 1994-05-18 EP disclosed
WO-1993003060-A1 AMIDE DERIVATIVES OF ANTIBIOTIC A 40926 GRUPPO LEPETIT S.P.A. (IT) 1993-02-18 WO disclosed
EP-0525499-A1 Amide derivatives of antibiotic A 40926 GRUPPO LEPETIT S.p.A. (IT) 1993-02-03 EP disclosed